Mechanistically, the protective effect mediated by Rb1 is achieved, at least in part, through direct activation of the NRF2-PPARγ-ACSL4 signaling axis, representing a novel therapeutic approach for AKI intervention. The gene discussed is RB1; the disease is acute kidney injury.